Trimeductan MR, 35 mg, tabletki o zmodyfikowanym uwalnianiu, Placebo for Trimeductan MR 35/Placebo dla Trimeductan MR 35 clinical trials

Impact of trimetazidine on endothelial function and biomarkers correlating with the prognosis of heart failure with preserved ejection fraction

This study is looking at a medicine called Trimeductan MR for people with a type of heart failure where the heart still pumps blood well. It wants to see if the medicine can reduce hospital stays for heart failure or prevent death, and how it affects heart health.